Lamotrigine augmentation in unipolar depression
Authors:
- Fabio Lopes RochaFRFabio Lopes Rocha
- Claudia HaraCHClaudia Hara
- 1 March 2003
- journal article
- Published by Wolters Kluwer Health in International Clinical Psychopharmacology
- Vol. 18 (2) , 97-99
Abstract
A significant number of patients with unipolar depression fail to achieve remission after one or a series of antidepressants. We present the results of a retrospective chart review of the efficacy and tolerability of lamotrigine as an augmentation drug in treatment-resistant unipolar depression. A previous absence of a response was defined as the clinically significant presence of depressive symptomatology after 6 weeks of treatment with an antidepressant, with at least 3 weeks at the maximum dose tolerated by the patient. The patients were rated retrospectively using the Clinical Global Impression rating scale. Seventy-six percent of the patients improved. Gender, age, basal severity of the episode and degree of previous non response were not statistically significantly associated with response to lamotrigine augmentation. Comorbidity showed a tendency to be negatively related with response to lamotrigine. Three patients abandoned the treatment with lamotrigine due to side-effects. Complaints were excessive somnolence, headache, dizziness, nausea and malaise. Data suggest that lamotrigine is a promising drug for treatment-refractory unipolar depression. Double-blind studies are necessary to confirm its use as an augmentation agent.Keywords
This publication has 10 references indexed in Scilit:
- Lamotrigine as an Augmentation Agent in Treatment-Resistant DepressionThe Journal of Clinical Psychiatry, 2002
- Lamotrigine as Adjunct to Paroxetine in Acute DepressionThe Journal of Clinical Psychiatry, 2002
- Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disordersBiological Psychiatry, 2002
- A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood DisordersJournal of Clinical Psychopharmacology, 2000
- Treatment of Bipolar Depression, a Review of the Literature and a Suggestion for an AlgorithmNeuropsychobiology, 2000
- Spectrum of Activity of Lamotrigine in Treatment-Refractory Bipolar DisorderAmerican Journal of Psychiatry, 1999
- A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I DepressionThe Journal of Clinical Psychiatry, 1999
- Comorbidity of major depression and panic disorderJournal of Clinical Psychology, 1998
- Is Interpersonal Psychotherapy Superior to Supportive Psychotherapy?American Journal of Psychiatry, 1996
- Lamotrigine – An UpdateCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1996